John Rim, Samsung Biologics CEO

Sam­sung Bi­o­log­ics to kick off $1.5B+ plant con­struc­tion in South Ko­rea

The CD­MO gi­ant Sam­sung Bi­o­log­ics will be start­ing the con­struc­tion of its man­u­fac­tur­ing plant at the Song­do site in South Ko­rea.

Sam­sung an­nounced to­day that it will in­vest over $1.5 bil­lion in the new fa­cil­i­ty. The CD­MO plans to break ground on the plant some­time in the first half of 2023, with it ful­ly op­er­a­tional by 2025.

The new plant, dubbed Plant 5, will al­so be the first piece to Sam­sung Bi­o­log­ic’s new Bio Cam­pus, known as Bio Cam­pus II. The fa­cil­i­ty will be 96,000 square me­ters or around 1,033,335 square feet and will be able to have a ca­pac­i­ty of 180,000 liters of prod­uct. Once Plant 5 is com­plete, this will bring the CD­MO’s man­u­fac­tur­ing ca­pac­i­ty to a to­tal of 784,000 liters of prod­uct.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.